Showing results (611-620 of 693) with videos related to

Sort By:
Pageof 70
Nature Neuroscience|July 10, 2023
Positron emission tomography and magnetic resonance imaging methods and datasets within the Dominantly Inherited Alzheimer Network (DIAN)Nicole S McKay, Brian A Gordon, Russ C Hornbeck, et al.
Cerebral Cortex (New York, N.Y. : 1991)|March 22, 2020
Global and Regional Development of the Human Cerebral Cortex: Molecular Architecture and Occupational AptitudesJean Shin, Shaojie Ma, Edith Hofer, et al.
Plos One|February 7, 2017
Identification of shared risk loci and pathways for bipolar disorder and schizophreniaAndreas J Forstner, Julian Hecker, Andrea Hofmann, et al.
Translational Psychiatry|November 12, 2015
Genome-wide analysis implicates microRNAs and their target genes in the development of bipolar disorderA J Forstner, A Hofmann, A Maaser, et al.
Molecular Psychiatry|March 23, 2019
The BDNFVal66Met SNP modulates the association between beta-amyloid and hippocampal disconnection in Alzheimer's diseaseNicolai Franzmeier, Jinyi Ren, Alexander Damm, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 21, 2024
Presenilin-1 mutation position influences amyloidosis, small vessel disease, and dementia with disease stageNelly Joseph-Mathurin, Rebecca L Feldman, Ruijin Lu, et al.
The Lancet. Neurology|March 22, 2025
Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open-label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU trialRandall J Bateman, Yan Li, Eric M McDade, et al.
American Journal of Human Genetics|March 1, 2011
Genome-wide association study identifies genetic variation in neurocan as a susceptibility factor for bipolar disorderSven Cichon, Thomas W Mühleisen, Franziska A Degenhardt, et al.
Biological Psychiatry|February 20, 2026
The link between weight gain and hippocampal atrophy in bipolar disorder - A longitudinal investigation in 934 participantsJulia Fraiha-Pegado, Sean R McWhinney, Martin Alda, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU TrialRandall J Bateman, Yan Li, Eric M McDade, et al.
Pageof 70